{
    "organizations": [],
    "uuid": "ce783185445ccebbdfb161063c78dbb2827dd803",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amgen-inc-q4-loss-per-share-589/brief-amgen-inc-q4-loss-per-share-5-89-idUSB8N19C050",
    "ord_in_thread": 0,
    "title": "BRIEF-Amgen Inc Q4 Loss Per Share $5.89",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Amgen Inc:\n* AMGEN QTRLY LOSS PER SHARE $5.89; QTRLY ADJUSTED EARNINGS PER SHARE $2.89; QTRLY REVENUE $5.80 BILLION, DOWN 3 PERCENT\n* AMGEN - QTRLY LOSS PER SHARE INCLUDES $6.1 BILLION CHARGE RELATED TO IMPACT OF U.S. TAX REFORM\n* AMGEN SEES 2018 TOTAL REVENUE $21.8 BILLION - $22.8 BILLION; SEES 2018 EARNINGS PER SHARE $11.18 - $12.36; SEES 2018 ADJUSTED EARNINGS PER SHARE $12.60 - $13.70\n* AMGEN SEES 2018 CAPITAL EXPENDITURES TO BE ABOUT $750 MILLION\n* AMGEN - ADDITIONAL $10 BILLION OF SHARE REPURCHASES AUTHORIZED\n* AMGEN - NEW INVESTMENT PLAN INCLUDES COMMITTING UP TO $300 MILLION TO BUILD NEW MANUFACTURING PLANT IN THE U.S.\n* AMGEN - EXPECTS TO INVEST ABOUT $3.5 BILLION IN CAPITAL EXPENDITURES OVER NEXT 5 YRS, WITH ABOUT 75 PERCENT OF INVESTMENT IN THE U.S.\n* AMGEN - EXPECTS TO FINALIZE EXACT LOCATION OF NEW MANUFACTURING PLANT IN Q2\n* AMGEN - INCREASING SIZE OF AMGEN VENTURES FUND, PROVIDING UP TO $300 MILLION GROWTH CAPITAL FOR EARLY STAGE, BIOTECH COS IN THE U.S. Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-02T05:13:00.000+02:00",
    "crawled": "2018-02-02T12:35:28.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "amgen",
        "inc",
        "amgen",
        "qtrly",
        "loss",
        "per",
        "share",
        "qtrly",
        "adjusted",
        "earnings",
        "per",
        "share",
        "qtrly",
        "revenue",
        "billion",
        "percent",
        "amgen",
        "qtrly",
        "loss",
        "per",
        "share",
        "includes",
        "billion",
        "charge",
        "related",
        "impact",
        "tax",
        "reform",
        "amgen",
        "see",
        "total",
        "revenue",
        "billion",
        "billion",
        "see",
        "earnings",
        "per",
        "share",
        "see",
        "adjusted",
        "earnings",
        "per",
        "share",
        "amgen",
        "see",
        "capital",
        "expenditure",
        "million",
        "amgen",
        "additional",
        "billion",
        "share",
        "repurchase",
        "authorized",
        "amgen",
        "new",
        "investment",
        "plan",
        "includes",
        "committing",
        "million",
        "build",
        "new",
        "manufacturing",
        "plant",
        "amgen",
        "expects",
        "invest",
        "billion",
        "capital",
        "expenditure",
        "next",
        "yr",
        "percent",
        "investment",
        "amgen",
        "expects",
        "finalize",
        "exact",
        "location",
        "new",
        "manufacturing",
        "plant",
        "q2",
        "amgen",
        "increasing",
        "size",
        "amgen",
        "venture",
        "fund",
        "providing",
        "million",
        "growth",
        "capital",
        "early",
        "stage",
        "biotech",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}